<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="vps35-pd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">vps35-pd</book-part-id>
      <title-group>
        <title><italic toggle="yes">VPS35</italic>-Related Parkinson Disease</title>
        <alt-title alt-title-type="alt-title">Synonym: PARK17</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Deutschl&#x000e4;nder</surname>
            <given-names>Angela</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Departments of Neurology, Neuroscience, and Clinical Genomics<break/>Mayo Clinic<break/>Jacksonville, Florida</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ross</surname>
            <given-names>Owen A</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Departments of Neuroscience and Clinical Genomics<break/>Mayo Clinic<break/>Jacksonville, Florida</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wszolek</surname>
            <given-names>Zbigniew K</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Mayo Clinic<break/>Jacksonville, Florida</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>10</day>
          <month>8</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="vldlr-ch" document-type="chapter"><italic toggle="yes">VLDLR</italic>-Associated Cerebellar Hypoplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="porphyria-var" document-type="chapter">Variegate Porphyria</related-object>
      <abstract id="vps35-pd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">VPS35</italic>-related Parkinson disease (<italic toggle="yes">VPS35</italic>-PD) is defined as Parkinson disease caused by heterozygous <italic toggle="yes">VPS35</italic> pathogenic variants. Currently, the only known <italic toggle="yes">VPS35</italic> variant with confirmed pathogenicity is c.1858G&#x0003e;A (p.Asp620Asn). Except for a younger age of onset, <italic toggle="yes">VPS35</italic>-PD is clinically indistinguishable from Parkinson disease of unknown cause (so-called sporadic Parkinson disease). Variability among 50 individuals reported with molecularly confirmed <italic toggle="yes">VPS35</italic>-PD includes age of onset (mean: 51.0&#x000b1;8.7 years; range: 34-68 years), Parkinson subtype (tremor, akinetic rigid, mixed), first motor symptom, course of the disease (unilateral onset and slow disease progression are typical; dyskinesia and motor fluctuations may occur), and presence/absence of neuropsychiatric manifestations (including depression, schizophrenia, learning difficulties, mild cognitive impairment, and dementia).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">VPS35</italic>-PD is established in a proband with at least two cardinal manifestations of Parkinson disease and the heterozygous <italic toggle="yes">VPS35</italic> pathogenic variant c.1858G&#x0003e;A (p.Asp620Asn) identified on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> To date, treatment of <italic toggle="yes">VPS35</italic>-PD does not differ from that of Parkinson disease in general. Drugs to treat motor manifestations include the precursor of dopamine, levodopa, in combination with a peripheral dopa decarboxylase inhibitor (carbidopa, benserazide), dopamine agonists, inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B), anticholinergics, and amantadine. A good response to levodopa is usually seen. Deep brain stimulation to the subthalamic nucleus is effective in treating motor fluctuations or dyskinesia. Effective treatments for neuropsychiatric and autonomic symptoms, which may be disabling, are limited. Patients benefit from physical, occupational, and speech therapies.</p>
          <p><italic toggle="yes">Surveillance:</italic> Follow-up clinical neurologic evaluations are recommended every three to 12 months (depending on clinical scenario) to assess tremor, hypokinesia, rigidity, gait, cognition, and neuropsychiatric symptoms as well as treatment effectiveness.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs that may induce or exacerbate parkinsonism include but are not limited to neuroleptics, antidepressants, calcium channel blockers, valproate, lithium, and amiodarone.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> No reports have addressed pregnancy management in women with <italic toggle="yes">VPS35</italic>-PD.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">VPS35</italic>-PD is inherited in an autosomal dominant manner. About 85% of affected individuals have an affected parent. Although about 15% of affected individuals are simplex cases (i.e., a single occurrence in a family), family data are insufficient to determine if the pathogenic variant is <italic toggle="yes">de novo</italic>. Each child of an individual with <italic toggle="yes">VPS35</italic>-PD has a 50% chance of inheriting the <italic toggle="yes">VPS35</italic> pathogenic variant. Once the <italic toggle="yes">VPS35</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="vps35-pd.Diagnosis">
        <title>Diagnosis</title>
        <p>Diagnostic criteria for Parkinson disease have been published [<xref ref-type="bibr" rid="vps35-pd.REF.berardelli.2013.16">Berardelli et al 2013</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.postuma.2015.1591">Postuma et al 2015</xref>].</p>
        <sec id="vps35-pd.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">VPS35</italic>-related Parkinson disease (<italic toggle="yes">VPS35</italic>-PD) <bold>should be considered</bold> in individuals with the following clinical and imaging findings (characteristic of all forms of PD) and a family history of PD.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <p>Cardinal manifestations of Parkinson disease including:</p>
          <list list-type="bullet">
            <list-item>
              <p>Resting tremor (rhythmic tremor usually of the hands and forearms when relaxed, which disappears with active limb movement)</p>
            </list-item>
            <list-item>
              <p>Hypokinesia (partial or complete loss of muscle movement)</p>
            </list-item>
            <list-item>
              <p>Rigidity (increased muscle tone resulting in resistance to passive movement)</p>
            </list-item>
            <list-item>
              <p>Disturbance of postural reflexes (which maintain posture during movement)</p>
            </list-item>
          </list>
          <p>Additional clinical characteristics:</p>
          <list list-type="bullet">
            <list-item>
              <p>Adult onset</p>
            </list-item>
            <list-item>
              <p>Typically unilateral onset</p>
            </list-item>
            <list-item>
              <p>Slow disease progression</p>
            </list-item>
            <list-item>
              <p>Good response to levodopa therapy</p>
            </list-item>
          </list>
          <p><bold>Neuroimaging.</bold> Normal cranial MRI</p>
          <p><bold>Family history</bold> consistent with autosomal dominant inheritance, which can also include simplex cases (i.e., a single occurrence in a family) caused by a <italic toggle="yes">de novo</italic> pathogenic variant</p>
        </sec>
        <sec id="vps35-pd.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">VPS35</italic>-PD <bold>is established</bold> in a proband with least two cardinal manifestations of Parkinson disease and the heterozygous <italic toggle="yes">VPS35</italic> pathogenic variant <xref ref-type="table" rid="vps35-pd.T.vps35_variants_discussed_in_t">c.1858G&#x0003e;A</xref> (p.Asp620Asn) identified on molecular genetic testing (see <xref ref-type="table" rid="vps35-pd.T.molecular_genetic_testing_use">Table 1</xref>). Note: To date, this is the only <italic toggle="yes">VPS35</italic> variant with confirmed pathogenicity. Other variants have been identified in persons with Parkinson disease but their pathogenicity remains equivocal (see <xref ref-type="sec" rid="vps35-pd.Molecular_Genetics">Molecular Genetics</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (multi-gene panel) and <bold>genomic testing</bold> (comprehensive genome sequencing).</p>
          <p>Gene-targeted testing requires the clinician to determine which gene(s) are likely involved, whereas genomic testing does not. Because the phenotypes of inherited Parkinson disease are largely indistinguishable, most individuals with <italic toggle="yes">VPS35</italic>-PD are diagnosed by the following <xref ref-type="sec" rid="vps35-pd.Recommended_Testing">recommended testing</xref> or <xref ref-type="sec" rid="vps35-pd.Testing_to_Consider">testing to be considered</xref>.</p>
          <sec id="vps35-pd.Recommended_Testing">
            <title>Recommended Testing</title>
            <p><bold>A multi-gene Parkinson disease panel</bold> including <italic toggle="yes">VPS35</italic> and other genes of interest (see <xref ref-type="sec" rid="vps35-pd.Differential_Diagnosis">Differential Diagnosis</xref>). Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of a condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying phenotype. Given the rarity of <italic toggle="yes">VPS35</italic>-related Parkinson disease, some panels for Parkinson disease may not include this gene.</p>
            <p>For more information on multi-gene panels, click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          </sec>
          <sec id="vps35-pd.Testing_to_Consider">
            <title>Testing to Consider</title>
            <p><bold>Comprehensive genome sequencing</bold> (when clinically available) includes exome sequencing and genome sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <p>Note: Single-gene testing (sequence analysis of <italic toggle="yes">VPS35)</italic> is typically not recommended. Because the phenotype overlaps with that of other inherited forms of Parkinson disease a multi-gene panel or exome sequencing are typically used in lieu of single-gene testing.</p>
            <table-wrap id="vps35-pd.T.molecular_genetic_testing_use" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in <italic toggle="yes">VPS35</italic>-Related Parkinson Disease</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">VPS35</italic>
                    </td>
                    <td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">24/24&#x000a0;<sup>4,&#x000a0;5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_vps35-pd.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="vps35-pd.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="vps35-pd" object-id="vps35-pd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="vps35-pd.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="vps35-pd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="vps35-pd.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Variants detected may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="vps35-pd.TF.1.4">
                  <label>4. </label>
                  <p><xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al [2011]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al [2012]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al [2012]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.lesage.2012.1449">Lesage et al [2012]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al [2012]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al [2012]</xref></p>
                </fn>
                <fn id="vps35-pd.TF.1.5">
                  <label>5. </label>
                  <p>To date, the pathogenic variant p.Asp620Asn has been found in four simplex cases (i.e., a single occurrence in a family) and 20 probands (index patients) with familial Parkinson disease.</p>
                </fn>
                <fn id="vps35-pd.TF.1.6">
                  <label>6. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="vps35-pd.TF.1.7">
                  <label>7. </label>
                  <p><xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.verstraeten.2012">Verstraeten et al [2012]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="vps35-pd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="vps35-pd.Clinical_Description">
          <title>Clinical Description</title>
          <p>To date, 24 probands with molecularly confirmed <italic toggle="yes">VPS35</italic>-related Parkinson disease (i.e., due to the p.Asp620Asn pathogenic variant) have been reported [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>]; 20 were familial and four were simplex cases (a single occurrence of <italic toggle="yes">VPS35</italic>-PD in a family). By testing at-risk relatives in the 20 familial cases, the authors confirmed the diagnosis of <italic toggle="yes">VPS35</italic>-PD in 26 additional individuals worldwide, bringing to 50 the total of number of individuals with molecularly confirmed <italic toggle="yes">VPS35</italic>-PD.</p>
          <p>Except for a younger age of onset<italic toggle="yes">, VPS35</italic>-PD is clinically undistinguishable from Parkinson disease of unknown cause. Variability within families with <italic toggle="yes">VPS35</italic>-PD includes age of onset, first motor symptom, prevailing motor manifestations throughout the course of the disease, and presence/absence of neuropsychiatric manifestations (e.g., depression, dementia).</p>
          <p><bold>Age of onset.</bold> Mean age at disease onset is 51.0&#x000b1;8.7 years (range: 34-68 years; n=50); 51.2% are female (22/43).</p>
          <p><bold>Parkinson subtype.</bold> While the tremor-dominant subtype of Parkinson disease (with leg tremor as the initial manifestation) was thought to be common [<xref ref-type="bibr" rid="vps35-pd.REF.wider.2008.465">Wider et al 2008</xref>], subsequently reported families had akinetic rigid and mixed subtypes of Parkinson disease, and some individuals never developed tremor [<xref ref-type="bibr" rid="vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>].</p>
          <p>
            <bold>Course of the disease</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Asymmetric presentation at disease onset is typical.</p>
            </list-item>
            <list-item>
              <p>The disease course is usually slowly progressive.</p>
            </list-item>
            <list-item>
              <p>Dyskinesia and motor fluctuations may occur.</p>
              <p>Of note, atypical motor findings, cerebellar signs, or ocular motor signs have not been reported.</p>
            </list-item>
          </list>
          <p>
            <bold>Neuropsychiatric manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Depression has been reported occasionally; in one family depression was common [<xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>In one family with <italic toggle="yes">VPS35</italic>-PD, schizophrenia was reported in two family members with Parkinson disease; however, it was not explicitly stated that the two individuals had been tested for the p.Asp620Asn variant [<xref ref-type="bibr" rid="vps35-pd.REF.wider.2008.465">Wider et al 2008</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>Learning difficulties, mild cognitive impairment, and dementia have been reported in several affected individuals.</p>
            </list-item>
          </list>
          <p>
            <bold>Other findings reported</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Impaired sense of smell [<xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.struhal.2014.755">Struhal et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Autonomic manifestations including orthostasis and gastrointestinal symptoms (constipation)</p>
            </list-item>
          </list>
          <p><bold>Functional imaging studies</bold> show presynaptic dopaminergic dysfunction, which is apparently indistinguishable from findings in Parkinson disease in general.</p>
          <p>Single photon emission computed tomography (SPECT) of cerebral blood flow was normal in one individual [<xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al 2012</xref>].</p>
          <p><sup>18</sup>F-fluorodopa positron emission tomography (PET) showed asymmetrically reduced striatal <sup>18</sup>F-fluorodopa uptake with a posterior predominance [<xref ref-type="bibr" rid="vps35-pd.REF.wider.2008.465">Wider et al 2008</xref>].</p>
          <p>[123I]-FP-CIT SPECT showed asymmetric tracer uptake [<xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>].</p>
          <p><bold>Transcranial sonography.</bold> In one individual with Parkinson disease that started with resting tremor on the left side, transcranial sonography performed after a disease course of about 15 years showed normal echogenicity of the left substantia nigra, whereas the bone window was insufficient to allow visualization on the right side [<xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>].</p>
        </sec>
        <sec id="vps35-pd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlation is possible as p.Asp620Asn is the only confirmed pathogenic variant to date.</p>
        </sec>
        <sec id="vps35-pd.Penetrance">
          <title>Penetrance</title>
          <p>The penetrance of the p.Asp620Asn variant is high and age dependent [<xref ref-type="bibr" rid="vps35-pd.REF.trinh.2014.1535">Trinh et al 2014</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.lill.2016.386">Lill 2016</xref>]. Of note, to date data are too limited to allow quantification of penetrance.</p>
          <p>Age-dependent penetrance (onset range: 34-68 years) is most likely reflected in the following information on ten unaffected individuals heterozygous for the p.Asp620Asn variant identified in families with <italic toggle="yes">VPS35</italic>-PD:</p>
          <list list-type="bullet">
            <list-item>
              <p>Six were age 62 years or younger [<xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Four were between ages 49 and 67 years [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>].</p>
            </list-item>
          </list>
          <p>The p.Asp620Asn variant is very rare and was not found in:</p>
          <list list-type="bullet">
            <list-item>
              <p>Control groups screened for <italic toggle="yes">VPS35</italic> variants, including <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al [2011]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al [2011]</xref>, and <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al [2012]</xref> &#x02013; of which the largest study [<xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al 2012</xref>] had 6513 individuals;</p>
            </list-item>
            <list-item>
              <p>The Genome Aggregation Database (gnomAD), which contains data for 123,136 exomes and 15,496 whole genomes [<xref ref-type="bibr" rid="vps35-pd.REF.lek.2016.285">Lek et al 2016</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="vps35-pd.Nomenclature">
          <title>Nomenclature</title>
          <p><italic toggle="yes">VPS35</italic>-related Parkinson disease is also referred to as &#x0201c;PARK-VPS35&#x0201d; per the alternative nomenclature system proposed by <xref ref-type="bibr" rid="vps35-pd.REF.marras.2012.1016">Marras et al [2012]</xref>.</p>
        </sec>
        <sec id="vps35-pd.Prevalence">
          <title>Prevalence</title>
          <p>To date 24 probands with <italic toggle="yes">VPS35</italic>-related Parkinson disease have been reported worldwide [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>]. Twenty were familial and four were simplex cases (a single occurrence of <italic toggle="yes">VPS35</italic>-PD in a family). By testing relatives at risk in the 20 familial cases, the authors confirmed the diagnosis of <italic toggle="yes">VPS35</italic>-PD in an additional 26 individuals.</p>
          <p>Nine studies with sample sizes greater than 500 patients with PD are available. They comprise a total of 19,294 individuals. In these nine studies, the <italic toggle="yes">VPS35</italic> p.Asp620Asn variant was identified in 12 familial index cases and three simplex cases [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.guo.2012.983">Guo et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zhang.2012.638">Zhang et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.chen.2013">Chen et al 2013</xref>].</p>
          <p>The prevalence of <italic toggle="yes">VPS35</italic>-PD ranged from 0.0% to 1.5% in the following specific patient populations which only included persons with familial PD:</p>
          <list list-type="bullet">
            <list-item>
              <p>2:131 in Austria [<xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>3:246 in France [<xref ref-type="bibr" rid="vps35-pd.REF.lesage.2012.1449">Lesage et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>3:300 in Japan [<xref ref-type="bibr" rid="vps35-pd.REF.ando.2012.1413">Ando et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>1:191 in the UK [<xref ref-type="bibr" rid="vps35-pd.REF.sheerin.2012.838.e1">Sheerin et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>0:475 and 0:250 in Italy [<xref ref-type="bibr" rid="vps35-pd.REF.guella.2012.800">Guella et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.gagliardi.2014.2422.e1">Gagliardi et al 2014</xref>]</p>
            </list-item>
          </list>
          <p>In one study (including both familial and simplex cases) heterozygote frequencies were 2:120 in Yemenite Jews and 1:199 in Tunisians [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>].</p>
          <p>The p.Asp620Asn variant was not found in 11 studies involving individuals with sporadic and familial Parkinson disease from Europe, the US, South Africa, China (4 studies), and India [<xref ref-type="bibr" rid="vps35-pd.REF.deng.2012.e96">Deng et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.guo.2012.983">Guo et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.verstraeten.2012">Verstraeten et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zhang.2012.638">Zhang et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.chen.2013">Chen et al 2013</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.nuytemans.2013.982">Nuytemans et al 2013</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sudhaman.2013.2442.e1">Sudhaman et al 2013</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.blanckenberg.2014.445.e1">Blanckenberg et al 2014</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kalinderi.2015.113">Kalinderi et al 2015</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.bandr_sciga.2016.210.e1">Bandr&#x000e9;s-Ciga et al 2016</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.t_r_k.2016.135">T&#x000f6;r&#x000f6;k et al 2016</xref>].</p>
          <p>The frequency of the <italic toggle="yes">VPS35</italic> p.Asp620Asn variant in the general (control) population is very low, and not exactly determined.</p>
        </sec>
      </sec>
      <sec id="vps35-pd.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>A second <italic toggle="yes">VPS35</italic> variant, p.Leu625Pro, was found <italic toggle="yes">de novo</italic> in one individual with early-onset Alzheimer disease [<xref ref-type="bibr" rid="vps35-pd.REF.roveletlecrux.2015.1046">Rovelet-Lecrux et al 2015</xref>]; however, data to date are too limited to determine if the Alzheimer disease in this individual resulted from the <italic toggle="yes">VPS35</italic> variant or was coincidental.</p>
      </sec>
      <sec id="vps35-pd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of <italic toggle="yes">VPS35</italic>-related Parkinson disease (<italic toggle="yes">VPS35</italic>-PD) includes <bold>Parkinson disease of unknown cause</bold> (sometimes referred to as idiopathic or sporadic Parkinson disease). Apart from a younger age at onset, the phenotype of <italic toggle="yes">VPS35</italic>-PD (onset at age 50.2&#x000b1;8.9 years) is clinically indistinguishable from sporadic Parkinson disease (average onset at 60 years). Thus, the differential diagnosis of <italic toggle="yes">VPS35</italic>-PD is the same as it is for PD in general (see <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>). In addition, an extensive list of differential diagnosis of familial parkinsonism can be found in the book chapter by <xref ref-type="bibr" rid="vps35-pd.REF.fujioka.2014">Fujioka &#x00026; Wszolek [2014]</xref>.</p>
      </sec>
      <sec id="vps35-pd.Management">
        <title>Management</title>
        <sec id="vps35-pd.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">VPS35</italic>-related Parkinson disease, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Perform neurologic examination including assessment of tremor, hypokinesia, rigidity, postural reflexes, gait (propulsion, arm swing, stride length), and autonomic findings (e.g., orthostasis).</p>
            </list-item>
            <list-item>
              <p>Assess cognitive function and psychiatric manifestations (e. g., hallucinations, delusions, depression, anxiety, sleep disorders).</p>
            </list-item>
            <list-item>
              <p>Evaluate levodopa response.</p>
            </list-item>
            <list-item>
              <p>Consider consultation with a clinical geneticist and/or genetic counselor.</p>
            </list-item>
          </list>
        </sec>
        <sec id="vps35-pd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>To date, the treatment of individuals with <italic toggle="yes">VPS35</italic>-PD does not differ from that of Parkinson disease in general. The following is a brief summary of recommended treatment for PD, based on extensive existing guidelines and recommendations for pharmacotherapy of motor and non-motor manifestations of PD as well as neurosurgical interventions for motor findings [<xref ref-type="bibr" rid="vps35-pd.REF.zesiewicz.2010.924">Zesiewicz et al 2010</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.oertel.a">Oertel et al 2011a</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.oertel.b">Oertel et al 2011b</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.seppi.2011.s42">Seppi et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.ferreira.2013.5">Ferreira et al 2013</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.odin.2015.1133">Odin et al 2015</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.trenkwalder.2015.1023">Trenkwalder et al 2015</xref>].</p>
          <p><bold>Pharmacotherapy.</bold> Drugs to treat motor manifestations include the precursor of dopamine, levodopa, in combination with a peripheral dopa decarboxylase inhibitor (carbidopa, benserazide), dopamine agonists, inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B), anticholinergics, and amantadine. A good levodopa response was seen in nearly all reported individuals with <italic toggle="yes">VPS35</italic>-PD.</p>
          <p>General recommendations for treatment of Parkinson disease of unknown cause include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>To reduce or delay side effects (e.g., dyskinesias, hallucinations, impulse control disorder) of levodopa and dopaminergic medication, doses should not exceed the levels required for a satisfactory clinical response. In younger patients, dopamine agonists should be given a preference.</p>
            </list-item>
            <list-item>
              <p>Dyskinesias can be treated with reduction of levodopa doses, use of dopamine receptor agonists, deep-brain stimulation, and continuous application of levodopa or apomorphine.</p>
            </list-item>
            <list-item>
              <p>Patients treated with ergot-derived dopamine agonists require periodic echocardiograms. Ergot-derived dopaminergic drugs should be discontinued if fibrotic heart-valve changes are revealed [<xref ref-type="bibr" rid="vps35-pd.REF.antonini.2007.826">Antonini &#x00026; Poewe 2007</xref>].</p>
            </list-item>
          </list>
          <p><bold>Deep brain stimulation</bold> to the subthalamic nucleus was repeatedly reported to be effective in the treatment of disabling motor fluctuations or dyskinesia in persons with <italic toggle="yes">VPS35</italic>-PD.</p>
          <p><bold>Other.</bold> Overall, effective treatment for neuropsychiatric and autonomic symptoms (which may be disabling) is limited. Atypical neuroleptic agents such as low-dose clozapine and reduction of dopaminergic therapy can decrease delusions and hallucinations. If depression occurs, it should be treated according to guidelines. Droxidopa may be used to treat orthostasis.</p>
          <p>Patients also benefit from physical, occupational, and speech therapy.</p>
        </sec>
        <sec id="vps35-pd.Surveillance">
          <title>Surveillance</title>
          <p>For <italic toggle="yes">VPS35</italic>-PD (as well as in Parkinson disease in general), follow-up clinical neurologic evaluations are recommended every three to 12 months (depending on the clinical scenario and the needs of the individual) to assess tremor, hypokinesia, rigidity, gait, cognition, and neuropsychiatric symptoms as well as treatment effectiveness.</p>
        </sec>
        <sec id="vps35-pd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Neuroleptic drugs may increase the severity of parkinsonism in <italic toggle="yes">VPS35</italic>-PD (as in Parkinson disease in general). In general, atypical neuroleptics are less likely to exacerbate parkinsonism than typical neuroleptics. Other drugs that may induce or exacerbate parkinsonism include but are not limited to antidepressants, calcium channel blockers, valproate, lithium, and amiodarone [<xref ref-type="bibr" rid="vps35-pd.REF.bondonguitton.2011.2226">Bondon-Guitton et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.bohlega.2013.215">Bohlega &#x00026; Al-Foghom 2013</xref>].</p>
        </sec>
        <sec id="vps35-pd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="vps35-pd.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="vps35-pd.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Reports addressing pregnancy management in women with <italic toggle="yes">VPS35</italic>-PD are not available. The effect of PD in general on pregnancy has not been well characterized, since pregnancy is uncommon in women with PD. While most reports indicate that disease manifestations worsen during pregnancy, improvement has also been described (for a review see <xref ref-type="bibr" rid="vps35-pd.REF.robottom.2008.1799">Robottom et al [2008]</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kranick.2010.665">Kranick et al [2010]</xref>).</p>
          <p>No long-term outcome data exist for children born to mothers with Parkinson disease.</p>
          <list list-type="bullet">
            <list-item>
              <p>Levodopa crosses the placenta and some animal models have shown that high doses of levodopa administered during pregnancy may induce skeletal and visceral malformations; however, in more than 30 cases reported in the literature, levodopa treatment during human pregnancy did not result in adverse fetal outcome [<xref ref-type="bibr" rid="vps35-pd.REF.scott.2005.1078">Scott &#x00026; Chowdhury 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Amantadine should be avoided during pregnancy, if possible, since adverse pregnancy outcomes have been reported in rats.</p>
            </list-item>
          </list>
          <p>Discussion of the risks and benefits of using a given medication during pregnancy should ideally take place prior to conception. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mothertobaby.org/">MotherToBaby</ext-link> to access further information on medication use during pregnancy.</p>
        </sec>
        <sec id="vps35-pd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="vps35-pd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="vps35-pd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">VPS35</italic>-related Parkinson disease is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="vps35-pd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>About 85% of individuals diagnosed with <italic toggle="yes">VPS35</italic>-PD have an affected parent. Intrafamilial variability is seen in age of disease onset, first motor symptom, prevailing motor manifestations, and presence/absence of neuropsychiatric manifestations (e.g., depression, dementia).</p>
            </list-item>
            <list-item>
              <p>About 15% of individuals with <italic toggle="yes">VPS35</italic>-PD represent simplex cases (i.e., a single occurrence in a family) however, the parents of these individuals have not been evaluated sufficiently to determine if the pathogenic variant occurred <italic toggle="yes">de novo</italic> in the proband<italic toggle="yes">.</italic> Therefore, the proportion of <italic toggle="yes">VPS35</italic>-PD caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Of note: Because the p.Asp620Asn variant is known to occur on different haplotypes, it is likely a mutational hot spot.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. No instances of germline mosaicism have been reported, although it is theoretically possible.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with <italic toggle="yes">VPS35</italic>-PD may appear to be negative because of failure to recognize the disorder in family members, age-related or reduced penetrance of the disease in a heterozygous parent, or early death of the parent before the onset of disease manifestations. Therefore, an apparently negative family history cannot be confirmed unless molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband has the <italic toggle="yes">VPS35</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%. The risk to sibs who inherit the <italic toggle="yes">VPS35</italic> pathogenic variant of developing disease increases with age (see <xref ref-type="sec" rid="vps35-pd.Penetrance">Penetrance</xref>).</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for <italic toggle="yes">VPS35</italic>-PD because of the possibility of age-related or reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">VPS35</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the empiric risk to sibs is approximately 1% because of the theoretic possibility of parental germline mosaicism [<xref ref-type="bibr" rid="vps35-pd.REF.rahbari.2016.126">Rahbari et al 2016</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with <italic toggle="yes">VPS35</italic>-PD has a 50% chance of inheriting the <italic toggle="yes">VPS35</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The probability that an offspring who has inherited a pathogenic variant will become symptomatic increases with age (see <xref ref-type="sec" rid="vps35-pd.Penetrance">Penetrance</xref>).</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the genetic status of the proband's parents: if a parent has the <italic toggle="yes">VPS35</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="vps35-pd.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Predictive testing (i.e., testing of asymptomatic, at-risk individuals)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Predictive testing for at-risk relatives is possible once the p.Asp620Asn pathogenic variant has been identified in an affected family member. The utility of predictive testing for a known familial <italic toggle="yes">VPS35</italic> pathogenic variant may be limited because current data suggest both age-related and reduced penetrance in <italic toggle="yes">VPS35</italic>-PD (see <xref ref-type="sec" rid="vps35-pd.Penetrance">Penetrance</xref>) [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.kumar.2012.1360">Kumar et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.trinh.2014.1535">Trinh et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals found to be heterozygous) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal genetic counseling prior to testing.</p>
            </list-item>
          </list>
          <p>
            <bold>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
            </list-item>
            <list-item>
              <p>For more information, see the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nsgc.org/p/bl/et/blogaid=860">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
            </list-item>
          </list>
          <p>Note: It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of <italic toggle="yes">VPS35</italic>-PD.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="vps35-pd.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">VPS35</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis&#x000a0;are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="vps35-pd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="vps35-pd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="vps35-pd.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">VPS35</italic> consists of approximately 29.6 kb with 17 exons. Reference sequences are listed in <xref ref-type="table" rid="vps35-pd.T.vps35_variants_discussed_in_t">Table 2</xref>.</p>
          <p><bold>Pathogenic variants.</bold> The c.1858G&#x0003e;A (p.Asp620Asn) variant in exon 15 is the only variant detected with confirmed evidence of pathogenicity. Because this variant is known to occur on different haplotypes, it is likely a mutational hot spot.</p>
          <p>Additional missense variants in <italic toggle="yes">VPS35</italic> found in at least one individual with Parkinson disease are listed in <xref ref-type="table" rid="vps35-pd.T.vps35_variants_discussed_in_t">Table 2</xref>. Because the few missense variants found in multiple individuals with Parkinson disease (p.Gly51Ser, p.Pro316Ser, p.Leu774Met) have also been found in controls, the data are currently insufficient to determine pathogenicity of these variants [<xref ref-type="bibr" rid="vps35-pd.REF.vilari_og_ell.2011.162">Vilari&#x000f1;o-G&#x000fc;ell et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zimprich.2011.168">Zimprich et al 2011</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.sharma.2012.721">Sharma et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.verstraeten.2012">Verstraeten et al 2012</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.nuytemans.2013.982">Nuytemans et al 2013</xref>].</p>
          <table-wrap id="vps35-pd.T.vps35_variants_discussed_in_t" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">VPS35</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                  <th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" rowspan="12" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Of uncertain significance</bold>
                  </td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.151G&#x0003e;A</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly51Ser</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_4" rowspan="13" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018206.5">NM_018206.5</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_060676.2">NP_060676.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.171G&#x0003e;A</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Met57Ile</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.723T&#x0003e;G</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile241Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.946C&#x0003e;T</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro316Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1520A&#x0003e;T</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr507Phe</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1570C&#x0003e;T</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg524Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1679T&#x0003e;C</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile560Thr</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1796A&#x0003e;G</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.His599Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1819A&#x0003e;G</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Met607Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2210C&#x0003e;T</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala737Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2320C&#x0003e;A</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu774Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2359G&#x0003e;A</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu787Lys</td>
                </tr>
                <tr>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1858G&#x0003e;A</td>
                  <td headers="hd_h_vps35-pd.T.vps35_variants_discussed_in_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asp620Asn</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">VPS35</italic> encodes a 796-amino acid protein with a molecular mass of 92 kd termed VPS35. The VPS35 protein is part of the retromer, an evolutionarily conserved complex that associates with the cytosolic face of endosomes. The retromer is involved in the retrograde transport of transmembrane cargo (receptors, including dopamine receptors, transporters, adhesion molecules, and other proteins) from endosomes to the trans-Golgi network and to the plasma membrane; its cargo proteins are either recycled or degraded.</p>
          <p>The human retromer comprises two assembling subunits: one consists of a trimeric complex of VPS35, VPS26, and VPS29 proteins and is also termed cargo-selective complex, the other consists of a sortin nexin dimer (SNX). VPS35 forms a horseshoe-shaped alpha-helical solenoid predicted to contain 33 helices [<xref ref-type="bibr" rid="vps35-pd.REF.lucas.2016.1623">Lucas et al 2016</xref>]. It functions as the central platform for binding to other retromer proteins. VPS35 also mediates the association with the WASH complex, which includes FAM21. FAM21 binds to VPS35 through its extended unstructured &#x02018;tail&#x02019; domain, thereby allowing WASH-dependent retromer-mediated sorting of proteins (for a review see <xref ref-type="bibr" rid="vps35-pd.REF.burd.2014.6">Burd &#x00026; Cullen [2014]</xref>).</p>
          <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">VPS35</italic> encoding p.Asp620Asn has been shown to fold correctly and to bind VPS29 and VPS26A normally; however, binding to FAM21 of the WASH complex was perturbed, resulting in impairment of recruitment of the WASH complex to endosomes, retromer-mediated sorting of proteins, and autophagy [<xref ref-type="bibr" rid="vps35-pd.REF.follett.2014.230">Follett et al 2014</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.mcgough.2014.1670">McGough et al 2014</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zavodszky.2014a.3828">Zavodszky et al 2014a</xref>, <xref ref-type="bibr" rid="vps35-pd.REF.zavodszky.2014b.2155">Zavodszky et al 2014b</xref>]. Of note, perturbed binding to FAM21 is compatible with a partial loss-of-function variant.</p>
          <p>In addition, p.Asp620Asn has been shown to:</p>
          <list list-type="bullet">
            <list-item>
              <p>Redistribute endosomes to a perinuclear localization [<xref ref-type="bibr" rid="vps35-pd.REF.follett.2014.230">Follett et al 2014</xref>];</p>
            </list-item>
            <list-item>
              <p>Enlarge endosomes [<xref ref-type="bibr" rid="vps35-pd.REF.follett.2014.230">Follett et al 2014</xref>];</p>
            </list-item>
            <list-item>
              <p>Disrupt the trafficking of cathepsin D, a lysosome protease responsible for degradation of &#x003b1;-synuclein [<xref ref-type="bibr" rid="vps35-pd.REF.follett.2014.230">Follett et al 2014</xref>];</p>
            </list-item>
            <list-item>
              <p>Lose its ability to interact with dopamine receptor D1 (DRD1), causing dysregulation of DRD1 trafficking and impairment of DRD1-mediated dopamine signaling [<xref ref-type="bibr" rid="vps35-pd.REF.wang.2016.22">Wang et al 2016</xref>].</p>
            </list-item>
          </list>
          <p><italic toggle="yes">VPS35</italic> encoding p.Arg524Trp (which remains to be proven to be pathogenic) resulted in the accumulation of intracellular &#x003b1;-synuclein-positive aggregates, while the retromer showed decreased endosomal association and impaired protein trafficking [<xref ref-type="bibr" rid="vps35-pd.REF.follett.2016.18283">Follett et al 2016</xref>].</p>
          <p>In animal models, p.Asp620Asn results:</p>
          <list list-type="bullet">
            <list-item>
              <p>In mouse: in a reduction of dopamine release in the caudate putamen of homozygous VPS35 p.Asp620Asn knock-in mice [<xref ref-type="bibr" rid="vps35-pd.REF.ishizu.2016.4507">Ishizu et al 2016</xref>];</p>
            </list-item>
            <list-item>
              <p>In rat: in marked degeneration of substantia nigra dopaminergic neurons, and axonal pathology [<xref ref-type="bibr" rid="vps35-pd.REF.tsika.2014.4621">Tsika et al 2014</xref>];</p>
            </list-item>
            <list-item>
              <p>In <italic toggle="yes">Drosophila</italic>: in poor mobility, shortened life span, and increased sensitivity to rotenone [<xref ref-type="bibr" rid="vps35-pd.REF.wang.2014.73">Wang et al 2014</xref>].</p>
            </list-item>
          </list>
          <p><italic toggle="yes">VPS35</italic> haploinsufficiency was found to increase Alzheimer disease neuropathology in mice [<xref ref-type="bibr" rid="vps35-pd.REF.wen.2011.765">Wen et al 2011</xref>].</p>
        </sec>
      </sec>
      <sec id="vps35-pd.References">
        <title>References</title>
        <ref-list id="vps35-pd.References.reflist0">
          <ref id="vps35-pd.REF.ando.2012.1413">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ando</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Funayama</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Li</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Kashihara</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Murakami</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Ishizu</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Toyoda</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Noguchi</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Hashimoto</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Nakano</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Sasaki</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Kokubo</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Kuzuhara</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Ogaki</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Yamashita</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Yoshino</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Hatano</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Tomiyama</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Hattori</surname>
                  <given-names>N.</given-names>
                </name>
              </person-group>
              <article-title>VPS35 mutation in Japanese patients with typical Parkinson's disease.</article-title>
              <source>Mov Disord.</source>
              <year>2012</year>
              <volume>27</volume>
              <fpage>1413</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">22991136</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.antonini.2007.826">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Antonini</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
              </person-group>
              <article-title>Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.</article-title>
              <source>Lancet Neurol.</source>
              <year>2007</year>
              <volume>6</volume>
              <fpage>826</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">17706566</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.bandr_sciga.2016.210.e1">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bandr&#x000e9;s-Ciga</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Mencacci</surname>
                  <given-names>NE</given-names>
                </name>
                <name name-style="western">
                  <surname>Dur&#x000e1;n</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Barrero</surname>
                  <given-names>FJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Escamilla-Sevilla</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Morgan</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Hehir</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Vives</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Hardy</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Pittman</surname>
                  <given-names>AM</given-names>
                </name>
              </person-group>
              <article-title>Analysis of the genetic variability in Parkinson's disease from Southern Spain.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2016</year>
              <volume>37</volume>
              <fpage>210.e1</fpage>
              <lpage>210.e5</lpage>
              <pub-id pub-id-type="pmid">26518746</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.berardelli.2013.16">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Berardelli</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Wenning</surname>
                  <given-names>GK</given-names>
                </name>
                <name name-style="western">
                  <surname>Antonini</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Berg</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Bloem</surname>
                  <given-names>BR</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonifati</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Brooks</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Burn</surname>
                  <given-names>DJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Colosimo</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Fanciulli</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Ferreira</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Gasser</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Grandas</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Kanovsky</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Kostic</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Kulisevsky</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Oertel</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Reese</surname>
                  <given-names>JP</given-names>
                </name>
                <name name-style="western">
                  <surname>Relja</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Ruzicka</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Schrag</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Seppi</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Taba</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Vidailhet</surname>
                  <given-names>M</given-names>
                </name>
              </person-group>
              <article-title>EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.</article-title>
              <source>Eur J Neurol.</source>
              <year>2013</year>
              <volume>20</volume>
              <fpage>16</fpage>
              <lpage>34</lpage>
              <pub-id pub-id-type="pmid">23279440</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.blanckenberg.2014.445.e1">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Blanckenberg</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Ntsapi</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Carr</surname>
                  <given-names>JA</given-names>
                </name>
                <name name-style="western">
                  <surname>Bardien</surname>
                  <given-names>S</given-names>
                </name>
              </person-group>
              <article-title>EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2014</year>
              <volume>35</volume>
              <fpage>445.e1</fpage>
              <lpage>3</lpage>
              <pub-id pub-id-type="pmid">24080171</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.bohlega.2013.215">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bohlega</surname>
                  <given-names>SA</given-names>
                </name>
                <name name-style="western">
                  <surname>Al-Foghom</surname>
                  <given-names>NB</given-names>
                </name>
              </person-group>
              <article-title>Drug-induced Parkinson&#x02019;s disease: a clinical review.</article-title>
              <source>Neurosciences (Riyadh)</source>
              <year>2013</year>
              <volume>18</volume>
              <fpage>215</fpage>
              <lpage>21</lpage>
              <pub-id pub-id-type="pmid">23887211</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.bondonguitton.2011.2226">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bondon-Guitton</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Perez-Lloret</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Bagheri</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Brefel</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Rascol</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Montastruc</surname>
                  <given-names>JL</given-names>
                </name>
              </person-group>
              <article-title>Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.</article-title>
              <source>Mov Disord.</source>
              <year>2011</year>
              <volume>26</volume>
              <fpage>2226</fpage>
              <lpage>31</lpage>
              <pub-id pub-id-type="pmid">21674626</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.burd.2014.6">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Burd</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Cullen</surname>
                  <given-names>PJ</given-names>
                </name>
              </person-group>
              <article-title>Retromer: a master conductor of endosome sorting.</article-title>
              <source>Cold Spring Harb Perspect Biol.</source>
              <year>2014</year>
              <fpage>6</fpage>
              <pub-id pub-id-type="pmid">24492709</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.chen.2013">
            <mixed-citation publication-type="other">Chen Y, Chen K, Song W, Chen X, Cao B, Huang R, Zhao B, Guo X, Burgunder J, Li J, Shang HF. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Neurobiol Aging. 2013;34:1709.e7-8.</mixed-citation>
          </ref>
          <ref id="vps35-pd.REF.deng.2012.e96">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Deng</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Xu</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Deng</surname>
                  <given-names>X</given-names>
                </name>
                <name name-style="western">
                  <surname>Song</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Zheng</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Gao</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Fan</surname>
                  <given-names>X</given-names>
                </name>
                <name name-style="western">
                  <surname>Tang</surname>
                  <given-names>J.</given-names>
                </name>
              </person-group>
              <article-title>VPS35 mutation in Chinese Han patients with late-onset Parkinson's disease.</article-title>
              <source>Eur J Neurol.</source>
              <year>2012</year>
              <volume>19</volume>
              <fpage>e96</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">22891780</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.ferreira.2013.5">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ferreira</surname>
                  <given-names>JJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Katzenschlager</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Bloem</surname>
                  <given-names>BR</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonuccelli</surname>
                  <given-names>U</given-names>
                </name>
                <name name-style="western">
                  <surname>Burn</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Deuschl</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Dietrichs</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Fabbrini</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Friedman</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kanovsky</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Kostic</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Nieuwboer</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Odin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Rascol</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Sampaio</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Sch&#x000fc;pbach</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Tolosa</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Trenkwalder</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Schapira</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Berardelli</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Oertel</surname>
                  <given-names>WH</given-names>
                </name>
              </person-group>
              <article-title>Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.</article-title>
              <source>Eur J Neurol.</source>
              <year>2013</year>
              <volume>20</volume>
              <fpage>5</fpage>
              <lpage>15</lpage>
              <pub-id pub-id-type="pmid">23279439</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.follett.2014.230">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Follett</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Norwood</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Hamilton</surname>
                  <given-names>NA</given-names>
                </name>
                <name name-style="western">
                  <surname>Mohan</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Kovtun</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Tay</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhe</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Wood</surname>
                  <given-names>SA</given-names>
                </name>
                <name name-style="western">
                  <surname>Mellick</surname>
                  <given-names>GD</given-names>
                </name>
                <name name-style="western">
                  <surname>Silburn</surname>
                  <given-names>PA</given-names>
                </name>
                <name name-style="western">
                  <surname>Collins</surname>
                  <given-names>BM</given-names>
                </name>
                <name name-style="western">
                  <surname>Bugarcic</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Teasdale</surname>
                  <given-names>RD</given-names>
                </name>
              </person-group>
              <article-title>The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.</article-title>
              <source>Traffic.</source>
              <year>2014</year>
              <volume>15</volume>
              <fpage>230</fpage>
              <lpage>44</lpage>
              <pub-id pub-id-type="pmid">24152121</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.follett.2016.18283">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Follett</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Bugarcic</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Yang</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Ariotti</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Norwood</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Collins</surname>
                  <given-names>BM</given-names>
                </name>
                <name name-style="western">
                  <surname>Parton</surname>
                  <given-names>RG</given-names>
                </name>
                <name name-style="western">
                  <surname>Teasdale</surname>
                  <given-names>RD</given-names>
                </name>
              </person-group>
              <article-title>Parkinson disease-linked Vps35 R524W mutation impairs the endosomal association of retromer and induces &#x003b1;-Synuclein aggregation.</article-title>
              <source>J Biol Chem.</source>
              <year>2016</year>
              <volume>291</volume>
              <fpage>18283</fpage>
              <lpage>98</lpage>
              <pub-id pub-id-type="pmid">27385586</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.fujioka.2014">
            <mixed-citation publication-type="book">Fujioka S, Wszolek ZK. Genetic parkinsonism. In: Erik Walters, Christian Baumann, eds. <italic toggle="yes">Parkinson Disease and Other Movement Disorders</italic>. VU University Press. 2014:321-361.</mixed-citation>
          </ref>
          <ref id="vps35-pd.REF.gagliardi.2014.2422.e1">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Gagliardi</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Annesi</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Tarantino</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Nicoletti</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Quattrone</surname>
                  <given-names>A.</given-names>
                </name>
              </person-group>
              <article-title>Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2014</year>
              <volume>35</volume>
              <fpage>2422.e1</fpage>
              <lpage>2</lpage>
              <pub-id pub-id-type="pmid">24854799</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.guella.2012.800">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Guella</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Sold&#x000e0;</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Cilia</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Pezzoli</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Asselta</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Duga</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Goldwurm</surname>
                  <given-names>S.</given-names>
                </name>
              </person-group>
              <article-title>The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.</article-title>
              <source>Mov Disord.</source>
              <year>2012</year>
              <volume>27</volume>
              <fpage>800</fpage>
              <lpage>1</lpage>
              <pub-id pub-id-type="pmid">22278960</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.guo.2012.983">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Guo</surname>
                  <given-names>JF</given-names>
                </name>
                <name name-style="western">
                  <surname>Sun</surname>
                  <given-names>QY</given-names>
                </name>
                <name name-style="western">
                  <surname>Lv</surname>
                  <given-names>ZY</given-names>
                </name>
                <name name-style="western">
                  <surname>Yu</surname>
                  <given-names>RL</given-names>
                </name>
                <name name-style="western">
                  <surname>Li</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>YH</given-names>
                </name>
                <name name-style="western">
                  <surname>Tian</surname>
                  <given-names>JY</given-names>
                </name>
                <name name-style="western">
                  <surname>Xia</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Yan</surname>
                  <given-names>XX</given-names>
                </name>
                <name name-style="western">
                  <surname>Tang</surname>
                  <given-names>BS</given-names>
                </name>
              </person-group>
              <article-title>VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.</article-title>
              <source>Parkinsonism Relat Disord.</source>
              <year>2012</year>
              <volume>18</volume>
              <fpage>983</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">22673036</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.ishizu.2016.4507">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ishizu</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Yui</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Hebisawa</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Aizawa</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Cui</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Fujita</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Hashimoto</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Ajioka</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Mizusawa</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Yokota</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Watase</surname>
                  <given-names>K</given-names>
                </name>
              </person-group>
              <article-title>Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.</article-title>
              <source>Hum Mol Genet.</source>
              <year>2016</year>
              <volume>25</volume>
              <fpage>4507</fpage>
              <lpage>17</lpage>
              <pub-id pub-id-type="pmid">28173004</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.kalinderi.2015.113">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Kalinderi</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Bostantjopoulou</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Katsarou</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Dimikiotou</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Fidani</surname>
                  <given-names>L.</given-names>
                </name>
              </person-group>
              <article-title>D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.</article-title>
              <source>Neurosci Lett.</source>
              <year>2015</year>
              <volume>606</volume>
              <fpage>113</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">26300542</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.kranick.2010.665">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Kranick</surname>
                  <given-names>SM</given-names>
                </name>
                <name name-style="western">
                  <surname>Mowry</surname>
                  <given-names>EM</given-names>
                </name>
                <name name-style="western">
                  <surname>Colcher</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Horn</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Golbe</surname>
                  <given-names>LI</given-names>
                </name>
              </person-group>
              <article-title>Movement disorders and pregnancy: a review of the literature.</article-title>
              <source>Mov Disord.</source>
              <year>2010</year>
              <volume>25</volume>
              <fpage>665</fpage>
              <lpage>71</lpage>
              <pub-id pub-id-type="pmid">20437535</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.kumar.2012.1360">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Kumar</surname>
                  <given-names>KR</given-names>
                </name>
                <name name-style="western">
                  <surname>Weissbach</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Heldmann</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Kasten</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Tunc</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Sue</surname>
                  <given-names>CM</given-names>
                </name>
                <name name-style="western">
                  <surname>Svetel</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Kosti&#x00107;</surname>
                  <given-names>VS</given-names>
                </name>
                <name name-style="western">
                  <surname>Segura-Aguilar</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Ramirez</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Simon</surname>
                  <given-names>DK</given-names>
                </name>
                <name name-style="western">
                  <surname>Vieregge</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>M&#x000fc;nte</surname>
                  <given-names>TF</given-names>
                </name>
                <name name-style="western">
                  <surname>Hagenah</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Klein</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Lohmann</surname>
                  <given-names>K</given-names>
                </name>
              </person-group>
              <article-title>Frequency of the D620N mutation in VPS35 in Parkinson disease.</article-title>
              <source>Arch Neurol.</source>
              <year>2012</year>
              <volume>69</volume>
              <fpage>1360</fpage>
              <lpage>4</lpage>
              <pub-id pub-id-type="pmid">22801713</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.lek.2016.285">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lek</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Karczewski</surname>
                  <given-names>KJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Minikel</surname>
                  <given-names>EV</given-names>
                </name>
                <name name-style="western">
                  <surname>Samocha</surname>
                  <given-names>KE</given-names>
                </name>
                <name name-style="western">
                  <surname>Banks</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Fennell</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>O'Donnell-Luria</surname>
                  <given-names>AH</given-names>
                </name>
                <name name-style="western">
                  <surname>Ware</surname>
                  <given-names>JS</given-names>
                </name>
                <name name-style="western">
                  <surname>Hill</surname>
                  <given-names>AJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Cummings</surname>
                  <given-names>BB</given-names>
                </name>
                <name name-style="western">
                  <surname>Tukiainen</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Birnbaum</surname>
                  <given-names>DP</given-names>
                </name>
                <name name-style="western">
                  <surname>Kosmicki</surname>
                  <given-names>JA</given-names>
                </name>
                <name name-style="western">
                  <surname>Duncan</surname>
                  <given-names>LE</given-names>
                </name>
                <name name-style="western">
                  <surname>Estrada</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhao</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Zou</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Pierce-Hoffman</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Berghout</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Cooper</surname>
                  <given-names>DN</given-names>
                </name>
                <name name-style="western">
                  <surname>Deflaux</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>DePristo</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Do</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Flannick</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Fromer</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Gauthier</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Goldstein</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Gupta</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Howrigan</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Kiezun</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kurki</surname>
                  <given-names>MI</given-names>
                </name>
                <name name-style="western">
                  <surname>Moonshine</surname>
                  <given-names>AL</given-names>
                </name>
                <name name-style="western">
                  <surname>Natarajan</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Orozco</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Peloso</surname>
                  <given-names>GM</given-names>
                </name>
                <name name-style="western">
                  <surname>Poplin</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Rivas</surname>
                  <given-names>MA</given-names>
                </name>
                <name name-style="western">
                  <surname>Ruano-Rubio</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Rose</surname>
                  <given-names>SA</given-names>
                </name>
                <name name-style="western">
                  <surname>Ruderfer</surname>
                  <given-names>DM</given-names>
                </name>
                <name name-style="western">
                  <surname>Shakir</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Stenson</surname>
                  <given-names>PD</given-names>
                </name>
                <name name-style="western">
                  <surname>Stevens</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Thomas</surname>
                  <given-names>BP</given-names>
                </name>
                <name name-style="western">
                  <surname>Tiao</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Tusie-Luna</surname>
                  <given-names>MT</given-names>
                </name>
                <name name-style="western">
                  <surname>Weisburd</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Won</surname>
                  <given-names>HH</given-names>
                </name>
                <name name-style="western">
                  <surname>Yu</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Altshuler</surname>
                  <given-names>DM</given-names>
                </name>
                <name name-style="western">
                  <surname>Ardissino</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Boehnke</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Danesh</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Donnelly</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Elosua</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Florez</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Gabriel</surname>
                  <given-names>SB</given-names>
                </name>
                <name name-style="western">
                  <surname>Getz</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Glatt</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Hultman</surname>
                  <given-names>CM</given-names>
                </name>
                <name name-style="western">
                  <surname>Kathiresan</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Laakso</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>McCarroll</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>McCarthy</surname>
                  <given-names>MI</given-names>
                </name>
                <name name-style="western">
                  <surname>McGovern</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>McPherson</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Neale</surname>
                  <given-names>BM</given-names>
                </name>
                <name name-style="western">
                  <surname>Palotie</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Purcell</surname>
                  <given-names>SM</given-names>
                </name>
                <name name-style="western">
                  <surname>Saleheen</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Scharf</surname>
                  <given-names>JM</given-names>
                </name>
                <name name-style="western">
                  <surname>Sklar</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Sullivan</surname>
                  <given-names>PF</given-names>
                </name>
                <name name-style="western">
                  <surname>Tuomilehto</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Tsuang</surname>
                  <given-names>MT</given-names>
                </name>
                <name name-style="western">
                  <surname>Watkins</surname>
                  <given-names>HC</given-names>
                </name>
                <name name-style="western">
                  <surname>Wilson</surname>
                  <given-names>JG</given-names>
                </name>
                <name name-style="western">
                  <surname>Daly</surname>
                  <given-names>MJ</given-names>
                </name>
                <name name-style="western">
                  <surname>MacArthur</surname>
                  <given-names>DG</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Analysis of protein-coding genetic variation in 60,706 humans.</article-title>
              <source>Nature.</source>
              <year>2016</year>
              <volume>536</volume>
              <fpage>285</fpage>
              <lpage>91</lpage>
              <pub-id pub-id-type="pmid">27535533</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.lesage.2012.1449">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lesage</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Condroyer</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Klebe</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Honor&#x000e9;</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Tison</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Brefel-Courbon</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>D&#x000fc;rr</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Brice</surname>
                  <given-names>A</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Identification of VPS35 mutations replicated in French families with Parkinson disease.</article-title>
              <source>Neurology.</source>
              <year>2012</year>
              <volume>78</volume>
              <fpage>1449</fpage>
              <lpage>50</lpage>
              <pub-id pub-id-type="pmid">22517097</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.lill.2016.386">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lill</surname>
                  <given-names>CM</given-names>
                </name>
              </person-group>
              <article-title>Genetics of Parkinson's disease.</article-title>
              <source>Mol Cell Probes.</source>
              <year>2016</year>
              <volume>30</volume>
              <fpage>386</fpage>
              <lpage>396</lpage>
              <pub-id pub-id-type="pmid">27818248</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.lucas.2016.1623">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lucas</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Gershlick</surname>
                  <given-names>DC</given-names>
                </name>
                <name name-style="western">
                  <surname>Vidaurrazaga</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Rojas</surname>
                  <given-names>AL</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonifacino</surname>
                  <given-names>JS</given-names>
                </name>
                <name name-style="western">
                  <surname>Hierro</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Structural mechanism for cargo recognition by the retromer complex.</article-title>
              <source>Cell.</source>
              <year>2016</year>
              <volume>167</volume>
              <fpage>1623</fpage>
              <lpage>35.e14</lpage>
              <pub-id pub-id-type="pmid">27889239</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.marras.2012.1016">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Marras</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Lohmann</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Lang</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Klein</surname>
                  <given-names>C</given-names>
                </name>
              </person-group>
              <article-title>Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.</article-title>
              <source>Neurology.</source>
              <year>2012</year>
              <volume>78</volume>
              <fpage>1016</fpage>
              <lpage>24</lpage>
              <pub-id pub-id-type="pmid">22454269</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.mcgough.2014.1670">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>McGough</surname>
                  <given-names>IJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Steinberg</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Jia</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Barbuti</surname>
                  <given-names>PA</given-names>
                </name>
                <name name-style="western">
                  <surname>McMillan</surname>
                  <given-names>KJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Heesom</surname>
                  <given-names>KJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Whone</surname>
                  <given-names>AL</given-names>
                </name>
                <name name-style="western">
                  <surname>Caldwell</surname>
                  <given-names>MA</given-names>
                </name>
                <name name-style="western">
                  <surname>Billadeau</surname>
                  <given-names>DD</given-names>
                </name>
                <name name-style="western">
                  <surname>Rosen</surname>
                  <given-names>MK</given-names>
                </name>
                <name name-style="western">
                  <surname>Cullen</surname>
                  <given-names>PJ</given-names>
                </name>
              </person-group>
              <article-title>Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.</article-title>
              <source>Curr Biol.</source>
              <year>2014</year>
              <volume>24</volume>
              <fpage>1670</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">24980502</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.nuytemans.2013.982">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Nuytemans</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Bademci</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Inchausti</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Dressen</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kinnamon</surname>
                  <given-names>DD</given-names>
                </name>
                <name name-style="western">
                  <surname>Mehta</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Z&#x000fc;chner</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Beecham</surname>
                  <given-names>GW</given-names>
                </name>
                <name name-style="western">
                  <surname>Martin</surname>
                  <given-names>ER</given-names>
                </name>
                <name name-style="western">
                  <surname>Scott</surname>
                  <given-names>WK</given-names>
                </name>
                <name name-style="western">
                  <surname>Vance</surname>
                  <given-names>JM</given-names>
                </name>
              </person-group>
              <article-title>Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.</article-title>
              <source>Neurology.</source>
              <year>2013</year>
              <volume>80</volume>
              <fpage>982</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">23408866</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.odin.2015.1133">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Odin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Ray Chaudhuri</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Slevin</surname>
                  <given-names>JT</given-names>
                </name>
                <name name-style="western">
                  <surname>Volkmann</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Dietrichs</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Martinez-Martin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Krauss</surname>
                  <given-names>JK</given-names>
                </name>
                <name name-style="western">
                  <surname>Henriksen</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Katzenschlager</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Antonini</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Rascol</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program.</article-title>
              <source>Parkinsonism Relat Disord.</source>
              <year>2015</year>
              <volume>21</volume>
              <fpage>1133</fpage>
              <lpage>44</lpage>
              <pub-id pub-id-type="pmid">26233582</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.oertel.a">
            <mixed-citation publication-type="book">Oertel WH, Berardelli A, Bloem BR, et al. Early (uncomplicated) Parkinson&#x02019;s disease. In: Gilhus NE, Barnes M, Brainin M, eds. <italic toggle="yes">European Handbook of Neurological Management.</italic> Vol 1. 2 ed. Oxford: Blackwell Publishing Ltd; 2011a: 217&#x02013;36.</mixed-citation>
          </ref>
          <ref id="vps35-pd.REF.oertel.b">
            <mixed-citation publication-type="book">Oertel WH, Berardelli A, Bloem BR, et al. Late (complicated) Parkinson&#x02019;s disease. In: Gilhus NE, Barnes M, Brainin M, eds. <italic toggle="yes">European Handbook of Neurological Management</italic>. Vol 1. 2 ed. Oxford: Blackwell Publishing Ltd; 2011b: 237&#x02013;67.</mixed-citation>
          </ref>
          <ref id="vps35-pd.REF.postuma.2015.1591">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Postuma</surname>
                  <given-names>RB</given-names>
                </name>
                <name name-style="western">
                  <surname>Berg</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Stern</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Olanow</surname>
                  <given-names>CW</given-names>
                </name>
                <name name-style="western">
                  <surname>Oertel</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Obeso</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Marek</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Litvan</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Lang</surname>
                  <given-names>AE</given-names>
                </name>
                <name name-style="western">
                  <surname>Halliday</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Goetz</surname>
                  <given-names>CG</given-names>
                </name>
                <name name-style="western">
                  <surname>Gasser</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Dubois</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Chan</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Bloem</surname>
                  <given-names>BR</given-names>
                </name>
                <name name-style="western">
                  <surname>Adler</surname>
                  <given-names>CH</given-names>
                </name>
                <name name-style="western">
                  <surname>Deuschl</surname>
                  <given-names>G</given-names>
                </name>
              </person-group>
              <article-title>MDS clinical diagnostic criteria for Parkinson's disease.</article-title>
              <source>Mov Disord.</source>
              <year>2015</year>
              <volume>30</volume>
              <fpage>1591</fpage>
              <lpage>601</lpage>
              <pub-id pub-id-type="pmid">26474316</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.robottom.2008.1799">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Robottom</surname>
                  <given-names>BJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Mullins</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Shulman</surname>
                  <given-names>LM</given-names>
                </name>
              </person-group>
              <article-title>Pregnancy in Parkinson's disease: case report and discussion.</article-title>
              <source>Expert Rev Neurother.</source>
              <year>2008</year>
              <volume>8</volume>
              <fpage>1799</fpage>
              <lpage>805</lpage>
              <pub-id pub-id-type="pmid">19086876</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.rahbari.2016.126">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Rahbari</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Wuster</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Lindsay</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Hardwick</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Alexandrov</surname>
                  <given-names>LB</given-names>
                </name>
                <name name-style="western">
                  <surname>Al Turki</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Dominiczak</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Morris</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Porteous</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Smith</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Stratton</surname>
                  <given-names>MR</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Timing, rates and spectra of human germline mutation.</article-title>
              <source>Nat Genet.</source>
              <year>2016</year>
              <volume>48</volume>
              <fpage>126</fpage>
              <lpage>33</lpage>
              <pub-id pub-id-type="pmid">26656846</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.roveletlecrux.2015.1046">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Rovelet-Lecrux</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Charbonnier</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Wallon</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Nicolas</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Seaman</surname>
                  <given-names>MN</given-names>
                </name>
                <name name-style="western">
                  <surname>Pottier</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Breusegem</surname>
                  <given-names>SY</given-names>
                </name>
                <name name-style="western">
                  <surname>Mathur</surname>
                  <given-names>PP</given-names>
                </name>
                <name name-style="western">
                  <surname>Jenardhanan</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Le Guennec</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Mukadam</surname>
                  <given-names>AS</given-names>
                </name>
                <name name-style="western">
                  <surname>Quenez</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Coutant</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Rousseau</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Richard</surname>
                  <given-names>AC</given-names>
                </name>
                <name name-style="western">
                  <surname>Boland</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Deleuze</surname>
                  <given-names>JF</given-names>
                </name>
                <name name-style="western">
                  <surname>Frebourg</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Hannequin</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Campion</surname>
                  <given-names>D</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>De novo deleterious genetic variations target a biological network centered on A&#x003b2; peptide in early-onset Alzheimer disease.</article-title>
              <source>Mol Psychiatry.</source>
              <year>2015</year>
              <volume>20</volume>
              <fpage>1046</fpage>
              <lpage>56</lpage>
              <pub-id pub-id-type="pmid">26194182</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.scott.2005.1078">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Scott</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Chowdhury</surname>
                  <given-names>M.</given-names>
                </name>
              </person-group>
              <article-title>Pregnancy in Parkinson's disease: unique case report and review of the literature.</article-title>
              <source>Mov Disord.</source>
              <year>2005</year>
              <volume>20</volume>
              <fpage>1078</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">16001415</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.seppi.2011.s42">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Seppi</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Weintraub</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Coelho</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Perez-Lloret</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Fox</surname>
                  <given-names>SH</given-names>
                </name>
                <name name-style="western">
                  <surname>Katzenschlager</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Hametner</surname>
                  <given-names>EM</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Rascol</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Goetz</surname>
                  <given-names>CG</given-names>
                </name>
                <name name-style="western">
                  <surname>Sampaio</surname>
                  <given-names>C</given-names>
                </name>
              </person-group>
              <article-title>The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.</article-title>
              <source>Mov Disord.</source>
              <year>2011</year>
              <volume>26</volume>
              <supplement>Suppl 3</supplement>
              <fpage>S42</fpage>
              <lpage>80</lpage>
              <pub-id pub-id-type="pmid">22021174</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.sharma.2012.721">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Sharma</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Ioannidis</surname>
                  <given-names>JP</given-names>
                </name>
                <name name-style="western">
                  <surname>Aasly</surname>
                  <given-names>JO</given-names>
                </name>
                <name name-style="western">
                  <surname>Annesi</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Brice</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Bertram</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Bozi</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Barcikowska</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Crosiers</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Clarke</surname>
                  <given-names>CE</given-names>
                </name>
                <name name-style="western">
                  <surname>Facheris</surname>
                  <given-names>MF</given-names>
                </name>
                <name name-style="western">
                  <surname>Farrer</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Garraux</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Gispert</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Auburger</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Hadjigeorgiou</surname>
                  <given-names>GM</given-names>
                </name>
                <name name-style="western">
                  <surname>Hicks</surname>
                  <given-names>AA</given-names>
                </name>
                <name name-style="western">
                  <surname>Hattori</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Jeon</surname>
                  <given-names>BS</given-names>
                </name>
                <name name-style="western">
                  <surname>Jamrozik</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Krygowska-Wajs</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Lesage</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Lill</surname>
                  <given-names>CM</given-names>
                </name>
                <name name-style="western">
                  <surname>Lin</surname>
                  <given-names>JJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Lynch</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Lichtner</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Lang</surname>
                  <given-names>AE</given-names>
                </name>
                <name name-style="western">
                  <surname>Libioulle</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Murata</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Mok</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Jasinska-Myga</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Mellick</surname>
                  <given-names>GD</given-names>
                </name>
                <name name-style="western">
                  <surname>Morrison</surname>
                  <given-names>KE</given-names>
                </name>
                <name name-style="western">
                  <surname>Meitnger</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Zimprich</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Opala</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Pramstaller</surname>
                  <given-names>PP</given-names>
                </name>
                <name name-style="western">
                  <surname>Pichler</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Park</surname>
                  <given-names>SS</given-names>
                </name>
                <name name-style="western">
                  <surname>Quattrone</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Rogaeva</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Ross</surname>
                  <given-names>OA</given-names>
                </name>
                <name name-style="western">
                  <surname>Stefanis</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Stockton</surname>
                  <given-names>JD</given-names>
                </name>
                <name name-style="western">
                  <surname>Satake</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Silburn</surname>
                  <given-names>PA</given-names>
                </name>
                <name name-style="western">
                  <surname>Strom</surname>
                  <given-names>TM</given-names>
                </name>
                <name name-style="western">
                  <surname>Theuns</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Tan</surname>
                  <given-names>EK</given-names>
                </name>
                <name name-style="western">
                  <surname>Toda</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Tomiyama</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Uitti</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Van Broeckhoven</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Wirdefeldt</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Wszolek</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Xiromerisiou</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Yomono</surname>
                  <given-names>HS</given-names>
                </name>
                <name name-style="western">
                  <surname>Yueh</surname>
                  <given-names>KC</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhao</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Gasser</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Maraganore</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Kr&#x000fc;ger</surname>
                  <given-names>R</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.</article-title>
              <source>J Med Genet.</source>
              <year>2012</year>
              <volume>49</volume>
              <fpage>721</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">23125461</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.sheerin.2012.838.e1">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Sheerin</surname>
                  <given-names>UM</given-names>
                </name>
                <name name-style="western">
                  <surname>Charlesworth</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Bras</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Guerreiro</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Bhatia</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Foltynie</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Limousin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Silveira-Moriyama</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Lees</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Wood</surname>
                  <given-names>N</given-names>
                </name>
              </person-group>
              <article-title>Screening for VPS35 mutations in Parkinson's disease.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2012</year>
              <volume>33</volume>
              <fpage>838.e1</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">22154191</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.struhal.2014.755">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Struhal</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Presslauer</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Spielberger</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Zimprich</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Auff</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Bruecke</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Ransmayr</surname>
                  <given-names>G</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>VPS35 Parkinson's disease phenotype resembles the sporadic disease.</article-title>
              <source>J Neural Transm (Vienna)</source>
              <year>2014</year>
              <volume>121</volume>
              <fpage>755</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">24557499</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.sudhaman.2013.2442.e1">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Sudhaman</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Behari</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Govindappa</surname>
                  <given-names>ST</given-names>
                </name>
                <name name-style="western">
                  <surname>Muthane</surname>
                  <given-names>UB</given-names>
                </name>
                <name name-style="western">
                  <surname>Juyal</surname>
                  <given-names>RC</given-names>
                </name>
                <name name-style="western">
                  <surname>Thelma</surname>
                  <given-names>BK</given-names>
                </name>
              </person-group>
              <article-title>VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2013</year>
              <volume>34</volume>
              <fpage>2442.e1</fpage>
              <lpage>3</lpage>
              <pub-id pub-id-type="pmid">23726718</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.trinh.2014.1535">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Trinh</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Guella</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Farrer</surname>
                  <given-names>MJ</given-names>
                </name>
              </person-group>
              <article-title>Disease penetrance of late-onset parkinsonism: a meta-analysis.</article-title>
              <source>JAMA Neurol.</source>
              <year>2014</year>
              <volume>71</volume>
              <fpage>1535</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">25330418</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.tsika.2014.4621">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Tsika</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Glauser</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Moser</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Fiser</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Daniel</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Sheerin</surname>
                  <given-names>UM</given-names>
                </name>
                <name name-style="western">
                  <surname>Lees</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Troncoso</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Lewis</surname>
                  <given-names>PA</given-names>
                </name>
                <name name-style="western">
                  <surname>Bandopadhyay</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Schneider</surname>
                  <given-names>BL</given-names>
                </name>
                <name name-style="western">
                  <surname>Moore</surname>
                  <given-names>DJ</given-names>
                </name>
              </person-group>
              <article-title>Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.</article-title>
              <source>Hum Mol Genet.</source>
              <year>2014</year>
              <volume>23</volume>
              <fpage>4621</fpage>
              <lpage>38</lpage>
              <pub-id pub-id-type="pmid">24740878</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.t_r_k.2016.135">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>T&#x000f6;r&#x000f6;k</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Z&#x000e1;dori</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>T&#x000f6;r&#x000f6;k</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Csility</surname>
                  <given-names>&#x000c9;</given-names>
                </name>
                <name name-style="western">
                  <surname>V&#x000e9;csei</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Kliv&#x000e9;nyi</surname>
                  <given-names>P.</given-names>
                </name>
              </person-group>
              <article-title>An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.</article-title>
              <source>Neurosci Lett.</source>
              <year>2016</year>
              <volume>610</volume>
              <fpage>135</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">26547032</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.trenkwalder.2015.1023">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Trenkwalder</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Chaudhuri</surname>
                  <given-names>KR</given-names>
                </name>
                <name name-style="western">
                  <surname>Garc&#x000ed;a Ruiz</surname>
                  <given-names>PJ</given-names>
                </name>
                <name name-style="western">
                  <surname>LeWitt</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Katzenschlager</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Sixel-D&#x000f6;ring</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Henriksen</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Sesar</surname>
                  <given-names>&#x000c1;</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Baker</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Ceballos-Baumann</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Deuschl</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Drapier</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Ebersbach</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Evans</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Fernandez</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Isaacson</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>van Laar</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Lees</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Lewis</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Mart&#x000ed;nez Castrillo</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Martinez-Martin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Odin</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>O'Sullivan</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Tagaris</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Wenzel</surname>
                  <given-names>K</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease: clinical practice recommendations.</article-title>
              <source>Parkinsonism Relat Disord.</source>
              <year>2015</year>
              <volume>21</volume>
              <fpage>1023</fpage>
              <lpage>30</lpage>
              <pub-id pub-id-type="pmid">26189414</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.verstraeten.2012">
            <mixed-citation publication-type="other">Verstraeten A, Wauters E, Crosiers D, Meeus B, Corsmit E, Elinck E, Mattheijssens M, Peeters K, Cras P, Pickut B, Vandenberghe R, Engelborghs S, De Deyn PP, Van Broeckhoven C, Theuns J. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiol Aging. 2012; 33:1844.e11-3.</mixed-citation>
          </ref>
          <ref id="vps35-pd.REF.vilari_og_ell.2011.162">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Wider</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Ross</surname>
                  <given-names>OA</given-names>
                </name>
                <name name-style="western">
                  <surname>Dachsel</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Kachergus</surname>
                  <given-names>JM</given-names>
                </name>
                <name name-style="western">
                  <surname>Lincoln</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Soto-Ortolaza</surname>
                  <given-names>AI</given-names>
                </name>
                <name name-style="western">
                  <surname>Cobb</surname>
                  <given-names>SA</given-names>
                </name>
                <name name-style="western">
                  <surname>Wilhoite</surname>
                  <given-names>GJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Bacon</surname>
                  <given-names>JA</given-names>
                </name>
                <name name-style="western">
                  <surname>Behrouz</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Melrose</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Hentati</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Puschmann</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Evans</surname>
                  <given-names>DM</given-names>
                </name>
                <name name-style="western">
                  <surname>Conibear</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Wasserman</surname>
                  <given-names>WW</given-names>
                </name>
                <name name-style="western">
                  <surname>Aasly</surname>
                  <given-names>JO</given-names>
                </name>
                <name name-style="western">
                  <surname>Burkhard</surname>
                  <given-names>PR</given-names>
                </name>
                <name name-style="western">
                  <surname>Djaldetti</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Ghika</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Hentati</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Krygowska-Wajs</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Lynch</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Melamed</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Rajput</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Rajput</surname>
                  <given-names>AH</given-names>
                </name>
                <name name-style="western">
                  <surname>Solida</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Wu</surname>
                  <given-names>RM</given-names>
                </name>
                <name name-style="western">
                  <surname>Uitti</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Wszolek</surname>
                  <given-names>ZK</given-names>
                </name>
                <name name-style="western">
                  <surname>Vingerhoets</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Farrer</surname>
                  <given-names>MJ</given-names>
                </name>
              </person-group>
              <article-title>VPS35 mutations in Parkinson disease.</article-title>
              <source>Am J Hum Genet.</source>
              <year>2011</year>
              <volume>89</volume>
              <fpage>162</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">21763482</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.wang.2016.22">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Niu</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhou</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Zheng</surname>
                  <given-names>X</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Tian</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Yu</surname>
                  <given-names>X</given-names>
                </name>
                <name name-style="western">
                  <surname>Bu</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Xu</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Ma</surname>
                  <given-names>Q</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>YW</given-names>
                </name>
              </person-group>
              <article-title>VPS35 regulates cell surface recycling and signaling of dopamine receptor D1.</article-title>
              <source>Neurobiol Aging.</source>
              <year>2016</year>
              <volume>46</volume>
              <fpage>22</fpage>
              <lpage>31</lpage>
              <pub-id pub-id-type="pmid">27460146</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.wang.2014.73">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>HS</given-names>
                </name>
                <name name-style="western">
                  <surname>Toh</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Ho</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Tio</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhao</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Tan</surname>
                  <given-names>EK</given-names>
                </name>
              </person-group>
              <article-title>In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila.</article-title>
              <source>Mol Brain.</source>
              <year>2014</year>
              <volume>7</volume>
              <fpage>73</fpage>
              <pub-id pub-id-type="pmid">25288323</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.wen.2011.765">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Wen</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Tang</surname>
                  <given-names>FL</given-names>
                </name>
                <name name-style="western">
                  <surname>Hong</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Luo</surname>
                  <given-names>SW</given-names>
                </name>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>CL</given-names>
                </name>
                <name name-style="western">
                  <surname>He</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Shen</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Jung</surname>
                  <given-names>JU</given-names>
                </name>
                <name name-style="western">
                  <surname>Xiong</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Lee</surname>
                  <given-names>DH</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>QG</given-names>
                </name>
                <name name-style="western">
                  <surname>Brann</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Kim</surname>
                  <given-names>TW</given-names>
                </name>
                <name name-style="western">
                  <surname>Yan</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Mei</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Xiong</surname>
                  <given-names>WC</given-names>
                </name>
              </person-group>
              <article-title>VPS35 haploinsufficiency increases Alzheimer's disease neuropathology.</article-title>
              <source>J Cell Biol.</source>
              <year>2011</year>
              <volume>195</volume>
              <fpage>765</fpage>
              <lpage>79</lpage>
              <pub-id pub-id-type="pmid">22105352</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.wider.2008.465">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Wider</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Skipper</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Solida</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Brown</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Farrer</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Dickson</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Wszolek</surname>
                  <given-names>ZK</given-names>
                </name>
                <name name-style="western">
                  <surname>Vingerhoets</surname>
                  <given-names>FJ</given-names>
                </name>
              </person-group>
              <article-title>Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.</article-title>
              <source>Parkinsonism Relat Disord.</source>
              <year>2008</year>
              <volume>14</volume>
              <fpage>465</fpage>
              <lpage>70</lpage>
              <pub-id pub-id-type="pmid">18342564</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.zavodszky.2014a.3828">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Zavodszky</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Seaman</surname>
                  <given-names>MN</given-names>
                </name>
                <name name-style="western">
                  <surname>Moreau</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Jimenez-Sanchez</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Breusegem</surname>
                  <given-names>SY</given-names>
                </name>
                <name name-style="western">
                  <surname>Harbour</surname>
                  <given-names>ME</given-names>
                </name>
                <name name-style="western">
                  <surname>Rubinsztein</surname>
                  <given-names>DC</given-names>
                </name>
              </person-group>
              <article-title>Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy.</article-title>
              <source>Nat Commun.</source>
              <year>2014a</year>
              <volume>5</volume>
              <fpage>3828</fpage>
              <pub-id pub-id-type="pmid">24819384</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.zavodszky.2014b.2155">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Zavodszky</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Seaman</surname>
                  <given-names>MN</given-names>
                </name>
                <name name-style="western">
                  <surname>Rubinsztein</surname>
                  <given-names>DC</given-names>
                </name>
              </person-group>
              <article-title>VPS35 Parkinson mutation impairs autophagy via WASH.</article-title>
              <source>Cell Cycle.</source>
              <year>2014b</year>
              <volume>13</volume>
              <fpage>2155</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">24963965</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.zesiewicz.2010.924">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Zesiewicz</surname>
                  <given-names>TA</given-names>
                </name>
                <name name-style="western">
                  <surname>Sullivan</surname>
                  <given-names>KL</given-names>
                </name>
                <name name-style="western">
                  <surname>Arnulf</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Chaudhuri</surname>
                  <given-names>KR</given-names>
                </name>
                <name name-style="western">
                  <surname>Morgan</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Gronseth</surname>
                  <given-names>GS</given-names>
                </name>
                <name name-style="western">
                  <surname>Miyasaki</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Iverson</surname>
                  <given-names>DJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Weiner</surname>
                  <given-names>WJ</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.</article-title>
              <source>Neurology.</source>
              <year>2010</year>
              <volume>74</volume>
              <fpage>924</fpage>
              <lpage>31</lpage>
              <pub-id pub-id-type="pmid">20231670</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.zhang.2012.638">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Chen</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Xiao</surname>
                  <given-names>Q</given-names>
                </name>
                <name name-style="western">
                  <surname>Cao</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Liu</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Rong</surname>
                  <given-names>TY</given-names>
                </name>
                <name name-style="western">
                  <surname>Ma</surname>
                  <given-names>JF</given-names>
                </name>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Wang</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Chen</surname>
                  <given-names>SD</given-names>
                </name>
              </person-group>
              <article-title>Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.</article-title>
              <source>Parkinsonism Relat Disord.</source>
              <year>2012</year>
              <volume>18</volume>
              <fpage>638</fpage>
              <lpage>40</lpage>
              <pub-id pub-id-type="pmid">22410496</pub-id>
            </element-citation>
          </ref>
          <ref id="vps35-pd.REF.zimprich.2011.168">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Zimprich</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Benet-Pag&#x000e8;s</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Struhal</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Graf</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Eck</surname>
                  <given-names>SH</given-names>
                </name>
                <name name-style="western">
                  <surname>Offman</surname>
                  <given-names>MN</given-names>
                </name>
                <name name-style="western">
                  <surname>Haubenberger</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Spielberger</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Schulte</surname>
                  <given-names>EC</given-names>
                </name>
                <name name-style="western">
                  <surname>Lichtner</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Rossle</surname>
                  <given-names>SC</given-names>
                </name>
                <name name-style="western">
                  <surname>Klopp</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Wolf</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Seppi</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Pirker</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Presslauer</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Mollenhauer</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Katzenschlager</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Foki</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Hotzy</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Reinthaler</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Harutyunyan</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kralovics</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Peters</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Zimprich</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Br&#x000fc;cke</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Poewe</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Auff</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Trenkwalder</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Rost</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Ransmayr</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Winkelmann</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Meitinger</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Strom</surname>
                  <given-names>TM</given-names>
                </name>
              </person-group>
              <article-title>A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.</article-title>
              <source>Am J Hum Genet.</source>
              <year>2011</year>
              <volume>89</volume>
              <fpage>168</fpage>
              <lpage>75</lpage>
              <pub-id pub-id-type="pmid">21763483</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
      <sec id="vps35-pd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="vps35-pd.Acknowledgments">
          <title>Acknowledgments</title>
          <p>AD is supported by the Max Kade foundation and the gift from Carl Edward Bolch, Jr and Susan Bass Bolch. This work is also supported by NINDS R01 NS078086 (OAR). ZKW is partially supported by the NIH/NINDS P50 NS072187, NIH/NIA (primary) and NIH/NINDS (secondary) 1U01AG045390-01A1, Mayo Clinic Center for Regenerative Medicine, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C and Sarah K Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), the gift from Carl Edward Bolch, Jr and Susan Bass Bolch, the Sol Goldman Charitable Trust, and Donald G and Jodi P Heeringa.</p>
        </sec>
        <sec id="vps35-pd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>10 August 2017 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>15 December 2016 (ad) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
